SUPRIYA Q2 FY27 ; STANDALONE

NET PROFIT DOWN 42.00% AT ₹29.25 CR (YOY), UP 21.66% (QOQ) REVENUE UP 3.23% AT ₹206.30 CR (YOY), UP 8.72% (QOQ) EBITDA DOWN 37.50% AT ₹45.40 CR (YOY), DOWN 4.33% (QOQ) MARGINS AT 22.01% VS 36.35% (YOY), 25.01% (QOQ)

Supriya Lifescience Ltd

Open attachment

← Back to feed